John W. Wiseman

BioPharmaceuticals R&D, AstraZeneca
Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Targeted Delivery of mRNA to the Heart via Extracellular Vesicles or Lipid Nanoparticles.

Targeted Delivery of mRNA to the Heart via Extracellular Vesicles or Lipid Nanoparticles.

Journal: Journal of extracellular vesicles

Published: December 15, 2025

Identification of cell type-specific cell-penetrating peptides through in vivo phage display leveraged by next generation sequencing.

Identification of cell type-specific cell-penetrating peptides through in vivo phage display leveraged by next generation sequencing.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 26, 2024

Barcoded Hybrids of Extracellular Vesicles and Lipid Nanoparticles for Multiplexed Analysis of Tissue Distribution.

Barcoded Hybrids of Extracellular Vesicles and Lipid Nanoparticles for Multiplexed Analysis of Tissue Distribution.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 10, 2024

In vivo phage display identifies novel peptides for cardiac targeting.

In vivo phage display identifies novel peptides for cardiac targeting.

Journal: Scientific reports

Published: January 24, 2024

Extracellular vesicles transport RNA between cells: Unraveling their dual role in diagnostics and therapeutics.

Extracellular vesicles transport RNA between cells: Unraveling their dual role in diagnostics and therapeutics.

Journal: Molecular aspects of medicine

Published: October 30, 2023

Creating Designer Engineered Extracellular Vesicles for Diverse Ligand Display, Target Recognition, and Controlled Protein Loading and Delivery.

Creating Designer Engineered Extracellular Vesicles for Diverse Ligand Display, Target Recognition, and Controlled Protein Loading and Delivery.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 30, 2023

Lipid Nanoparticles Deliver the Therapeutic VEGFA mRNA In Vitro and In Vivo and Transform Extracellular Vesicles for Their Functional Extensions.

Lipid Nanoparticles Deliver the Therapeutic VEGFA mRNA In Vitro and In Vivo and Transform Extracellular Vesicles for Their Functional Extensions.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 23, 2022

PA28α overexpressing female mice maintain exploratory behavior and capacity to prevent protein aggregation in hippocampus as they age.

PA28α overexpressing female mice maintain exploratory behavior and capacity to prevent protein aggregation in hippocampus as they age.

Journal: Aging cell

Published: October 19, 2020

H2O2-induced cataract as a model of age-related cataract: Lessons learned from overexpressing the proteasome activator PA28αβ in mouse eye lens.

H2O2-induced cataract as a model of age-related cataract: Lessons learned from overexpressing the proteasome activator PA28αβ in mouse eye lens.

Journal: Experimental eye research

Published: July 02, 2020

EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity.

EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity.

Journal: eLife

Published: April 09, 2020

Endothelin-1 Mediates the Systemic and Renal Hemodynamic Effects of GPR81 Activation.

Endothelin-1 Mediates the Systemic and Renal Hemodynamic Effects of GPR81 Activation.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: March 24, 2020

Conclusions from a behavioral aging study on male and female F2 hybrid mice on age-related behavior, buoyancy in water-based tests, and an ethical method to assess lifespan.

Conclusions from a behavioral aging study on male and female F2 hybrid mice on age-related behavior, buoyancy in water-based tests, and an ethical method to assess lifespan.

Journal: Aging

Published: May 23, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026